{
    "table_name": "clinical_tier1_diagnosis_r4",
    "table_fullname": "isb-cgc-bq.HTAN_versioned.clinical_tier1_diagnosis_r4",
    "column_names": [
        "ISS_Stage",
        "Tumor_Depth",
        "Residual_Disease",
        "International_Prognostic_Index",
        "Days_to_Last_Known_Disease_Status",
        "Primary_Gleason_Grade",
        "IRS_Group",
        "AJCC_Clinical_M",
        "Lymphatic_Invasion_Present",
        "Lymph_Nodes_Tested",
        "Anaplasia_Present",
        "Gleason_Grade_Tertiary",
        "AJCC_Clinical_N",
        "Breslow_Thickness",
        "Progression_or_Recurrence_Type",
        "Days_to_Progression",
        "Margin_Distance",
        "Cog_Neuroblastoma_Risk_Group",
        "Prior_Treatment",
        "INSS_Stage",
        "Days_to_Last_Follow_up",
        "Greatest_Tumor_Dimension",
        "Synchronous_Malignancy",
        "Tumor_Largest_Dimension_Diameter",
        "Prior_Malignancy",
        "Days_to_Recurrence",
        "Tumor_Confined_to_Organ_of_Origin",
        "INPC_Histologic_Group",
        "Micropapillary_Features",
        "Ovarian_Specimen_Status",
        "entityId",
        "Margins_Involved_Site",
        "Metastasis_at_Diagnosis",
        "IGCCCG_Stage",
        "Primary_Diagnosis",
        "Laterality",
        "Morphology",
        "Cog_Rhabdomyosarcoma_Risk_Group",
        "Tumor_Grade",
        "Gross_Tumor_Weight",
        "Perineural_Invasion_Present",
        "Ovarian_Surface_Involvement",
        "Method_of_Diagnosis",
        "Pregnant_at_Diagnosis",
        "Mitosis_Karyorrhexis_Index",
        "AJCC_Clinical_T",
        "Secondary_Gleason_Grade",
        "Id",
        "Lymph_Node_Involved_Site",
        "Metastasis_at_Diagnosis_Site",
        "Tumor_Focality",
        "First_Symptom_Prior_to_Diagnosis",
        "Last_Known_Disease_Status",
        "Progression_or_Recurrence_Anatomic_Site",
        "Vascular_Invasion_Present",
        "Component",
        "Vascular_Invasion_Type",
        "AJCC_Pathologic_N",
        "INRG_Stage",
        "WHO_NTE_Grade",
        "Site_of_Resection_or_Biopsy",
        "Anaplasia_Present_Type",
        "AJCC_Pathologic_Stage",
        "AJCC_Clinical_Stage",
        "Year_of_Diagnosis",
        "Non_Nodal_Tumor_Deposits",
        "Tissue_or_Organ_of_Origin",
        "Age_at_Diagnosis",
        "AJCC_Staging_System_Edition",
        "INPC_Grade",
        "Best_Overall_Response",
        "Medulloblastoma_Molecular_Classification",
        "AJCC_Pathologic_M",
        "Gleason_Grade_Group",
        "Lymph_Nodes_Positive",
        "Gleason_Patterns_Percent",
        "WHO_CNS_Grade",
        "AJCC_Pathologic_T",
        "Days_to_Diagnosis",
        "HTAN_Participant_ID",
        "Progression_or_Recurrence",
        "IRS_Stage",
        "Percent_Tumor_Invasion",
        "Non_Nodal_Regional_Disease",
        "Days_to_Progression_Free",
        "Classification_of_Tumor",
        "Peritoneal_Fluid_Cytological_Status",
        "Mitotic_Count",
        "Supratentorial_Localization",
        "HTAN_Center",
        "Manifest_Id",
        "Manifest_Version"
    ],
    "column_types": [
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "INT64"
    ],
    "nested_column_names": [
        "ISS_Stage",
        "Tumor_Depth",
        "Residual_Disease",
        "International_Prognostic_Index",
        "Days_to_Last_Known_Disease_Status",
        "Primary_Gleason_Grade",
        "IRS_Group",
        "AJCC_Clinical_M",
        "Lymphatic_Invasion_Present",
        "Lymph_Nodes_Tested",
        "Anaplasia_Present",
        "Gleason_Grade_Tertiary",
        "AJCC_Clinical_N",
        "Breslow_Thickness",
        "Progression_or_Recurrence_Type",
        "Days_to_Progression",
        "Margin_Distance",
        "Cog_Neuroblastoma_Risk_Group",
        "Prior_Treatment",
        "INSS_Stage",
        "Days_to_Last_Follow_up",
        "Greatest_Tumor_Dimension",
        "Synchronous_Malignancy",
        "Tumor_Largest_Dimension_Diameter",
        "Prior_Malignancy",
        "Days_to_Recurrence",
        "Tumor_Confined_to_Organ_of_Origin",
        "INPC_Histologic_Group",
        "Micropapillary_Features",
        "Ovarian_Specimen_Status",
        "entityId",
        "Margins_Involved_Site",
        "Metastasis_at_Diagnosis",
        "IGCCCG_Stage",
        "Primary_Diagnosis",
        "Laterality",
        "Morphology",
        "Cog_Rhabdomyosarcoma_Risk_Group",
        "Tumor_Grade",
        "Gross_Tumor_Weight",
        "Perineural_Invasion_Present",
        "Ovarian_Surface_Involvement",
        "Method_of_Diagnosis",
        "Pregnant_at_Diagnosis",
        "Mitosis_Karyorrhexis_Index",
        "AJCC_Clinical_T",
        "Secondary_Gleason_Grade",
        "Id",
        "Lymph_Node_Involved_Site",
        "Metastasis_at_Diagnosis_Site",
        "Tumor_Focality",
        "First_Symptom_Prior_to_Diagnosis",
        "Last_Known_Disease_Status",
        "Progression_or_Recurrence_Anatomic_Site",
        "Vascular_Invasion_Present",
        "Component",
        "Vascular_Invasion_Type",
        "AJCC_Pathologic_N",
        "INRG_Stage",
        "WHO_NTE_Grade",
        "Site_of_Resection_or_Biopsy",
        "Anaplasia_Present_Type",
        "AJCC_Pathologic_Stage",
        "AJCC_Clinical_Stage",
        "Year_of_Diagnosis",
        "Non_Nodal_Tumor_Deposits",
        "Tissue_or_Organ_of_Origin",
        "Age_at_Diagnosis",
        "AJCC_Staging_System_Edition",
        "INPC_Grade",
        "Best_Overall_Response",
        "Medulloblastoma_Molecular_Classification",
        "AJCC_Pathologic_M",
        "Gleason_Grade_Group",
        "Lymph_Nodes_Positive",
        "Gleason_Patterns_Percent",
        "WHO_CNS_Grade",
        "AJCC_Pathologic_T",
        "Days_to_Diagnosis",
        "HTAN_Participant_ID",
        "Progression_or_Recurrence",
        "IRS_Stage",
        "Percent_Tumor_Invasion",
        "Non_Nodal_Regional_Disease",
        "Days_to_Progression_Free",
        "Classification_of_Tumor",
        "Peritoneal_Fluid_Cytological_Status",
        "Mitotic_Count",
        "Supratentorial_Localization",
        "HTAN_Center",
        "Manifest_Id",
        "Manifest_Version"
    ],
    "nested_column_types": [
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "INT64"
    ],
    "description": [
        "The multiple myeloma disease stage at diagnosis.",
        "Numeric value that represents the depth of tumor invasion, measured in millimeters (mm).",
        "Text terms to describe the status of a tissue margin following surgical resection.",
        "The text term used to describe the International Prognostic Index, which classifies the prognosis of patients with aggressive non-Hodgkin's lymphoma.",
        "Time interval from the date of last follow up to the date of initial pathologic diagnosis, represented as a calculated number of days. If not applicable please enter 'Not Applicable'",
        "The text term used to describe the primary Gleason score, which describes the pattern of cells making up the largest area of the tumor. The primary and secondary Gleason pattern grades are combined to determine the patient's Gleason grade group, which is used to determine the aggresiveness of prostate cancer. Note that this grade describes the entire prostatectomy specimen and is not specific to the sample used for sequencing.",
        "Text term used to describe the classification of rhabdomyosarcoma tumors, as defined by the Intergroup Rhabdomyosarcoma Study (IRS).",
        "Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.",
        "A yes/no indicator to ask if small or thin-walled vessel invasion is present, indicating lymphatic involvement",
        "The number of lymph nodes tested to determine whether lymph nodes were involved with disease as determined by a pathologic examination.",
        "Yes/no/unknown/Not Reported indicator used to describe whether anaplasia was present at the time of diagnosis.",
        "The text term used to describe the tertiary pattern as described by the Gleason Grading System.",
        "Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.",
        "The number that describes the distance, in millimeters, between the upper layer of the epidermis and the deepest point of tumor penetration.",
        "The text term used to describe the type of progressive or recurrent disease or relapsed disease.",
        "Number of days between the date used for index and the date the patient's disease progressed. If not applicable please enter 'Not Applicable'",
        "Numeric value (in centimeters) that represents the distance between the tumor and the surgical margin.",
        "Text term that represents the categorization of patients on the basis of prognostic factors per a system developed by Children's Oncology Group (COG). Risk level is used to assign treatment intensity.",
        "A yes/no/unknown/not applicable indicator related to the administration of therapeutic agents received before the body specimen was collected.",
        "Text term used to describe the staging classification of neuroblastic tumors, as defined by the International Neuroblastoma Staging System (INSS).",
        "Time interval from the date of last follow up to the date of initial pathologic diagnosis, represented as a calculated number of days. If not applicable please enter 'Not Applicable'",
        "Numeric value that represents the measurement of the widest portion of the tumor in centimeters.",
        "A yes/no/unknown indicator used to describe whether the patient had an additional malignant diagnosis at the same time the tumor used for sequencing was diagnosed. If both tumors were sequenced, both tumors would have synchronous malignancies.",
        "Numeric value used to describe the maximum diameter or dimension of the primary tumor, measured in centimeters.",
        "The yes/no/unknown indicator used to describe the patient's history of prior cancer diagnosis.",
        "Number of days between the date used for index and the date the patient's disease recurred. If not applicable please enter 'Not Applicable'",
        "The yes/no/unknown indicator used to describe whether the tumor is confined to the organ where it originated and did not spread to a proximal or distant location within the body.",
        "The text term used to describe the classification of neuroblastomas distinguishing between favorable and unfavorable histologic groups. The histologic score, defined by the International Neuroblastoma Pathology Classification (INPC), is based on age, mitosis-karyorrhexis index (MKI), stromal content and degree of tumor cell differentiation.",
        "The yes/no/unknown indicator used to describe whether micropapillary features were determined to be present.",
        "The text term used to describe the physical condition of the involved ovary.",
        "Synapse ID of entity",
        "The text term used to describe the anatomic sites that were involved in the survival margins.",
        "The text term used to describe the extent of metastatic disease present at diagnosis.",
        "The text term used to describe the International Germ Cell Cancer Collaborative Group (IGCCCG), a grouping used to further classify metastatic testicular tumors.",
        "Text term used to describe the patient's histologic diagnosis, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).",
        "For tumors in paired organs, designates the side on which the cancer originates.",
        "The third edition of the International Classification of Diseases for Oncology, published in 2000 used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms. The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs. In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains. A system of numbered categories for representation of data.",
        "Text term used to describe the classification of rhabdomyosarcoma, as defined by the Children's Oncology Group (COG).",
        "Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.",
        "Numeric value used to describe the gross pathologic tumor weight, measured in grams.",
        "A yes/no indicator to ask if perineural invasion or infiltration of tumor or cancer is present.",
        "The text term that describes whether the surface tissue (outer boundary) of the ovary shows evidence of involvement or presence of cancer.",
        "Text term used to describe the method used to confirm the patients malignant diagnosis.",
        "The text term used to indicate whether the patient was pregnant at the time they were diagnosed.",
        "Text term that represents the component of the International Neuroblastoma Pathology Classification (INPC) for mitosis-karyorrhexis index (MKI).",
        "Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.",
        "The text term used to describe the secondary Gleason score, which describes the pattern of cells making up the second largest area of the tumor. The primary and secondary Gleason pattern grades are combined to determine the patient's Gleason grade group, which is used to determine the aggresiveness of prostate cancer. Note that this grade describes the entire prostatectomy specimen and is not specific to the sample used for sequencing.",
        "Unique identifier of entity e.g. a96059eb-81af-4b24-ae50-9242c0d8f819",
        "The text term used to describe the anatomic site of lymph node involvement.",
        "Text term to identify an anatomic site in which metastatic disease involvement is found.",
        "The text term used to describe whether the patient's disease originated in a single location or multiple locations.",
        "Text term used to describe the patient's first symptom experienced prior to diagnosis and thought to be related to the disease.",
        "Text term that describes the last known state or condition of an individual's neoplasm.",
        "The text term used to describe the anatomic site of resection; biopsy; tissue or organ of biospecimen origin; progression or recurrent disease; treatment",
        "The yes/no indicator to ask if large vessel or venous invasion was detected by surgery or presence in a tumor specimen.",
        "Category of metadata (e.g. Diagnosis, Biospecimen, scRNA-seq Level 1, etc.); provide the same one for all items/rows.",
        "Text term that represents the type of vascular tumor invasion.",
        "The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
        "The text term used to describe the staging classification of neuroblastic tumors, as defined by the International Neuroblastoma Risk Group (INRG).",
        "WHO NTE Grade",
        "The text term used to describe the anatomic site of the resection or biopsy of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).",
        "The text term used to describe the morphologic findings indicating the presence of a malignant cellular infiltrate characterized by the presence of large pleomorphic cells, necrosis, and high mitotic activity in a tissue sample.",
        "The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.",
        "Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.",
        "Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.",
        "The yes/no/unknown indicator used to describe the presence of tumor deposits in the pericolic or perirectal fat or in adjacent mesentery away from the leading edge of the tumor.",
        "The text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).",
        "Age at the time of diagnosis expressed in number of days since birth.",
        "The text term used to describe the version or edition of the American Joint Committee on Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.",
        "Text term used to describe the classification of neuroblastic differentiation within neuroblastoma tumors, as defined by the International Neuroblastoma Pathology Classification (INPC).",
        "The best improvement achieved throughout the entire course of protocol treatment.",
        "The text term used to describe the classification of medulloblastoma tumors based on molecular features.",
        "Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).",
        "The text term used to describe the overall grouping of grades defined by the Gleason grading classification, which is used to determine the aggressiveness of prostate cancer. Note that this grade describes the entire prostatectomy specimen and is not specific to the sample used for sequencing.",
        "The number of lymph nodes involved with disease as determined by pathologic examination.",
        "Numeric value that represents the percentage of Patterns 4 and 5, which is used when the Gleason score is greater than 7 to predict prognosis.",
        "WHO CNS Grade",
        "Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).",
        "Number of days between the date used for index and the date the patient was diagnosed with the malignant disease. If not applicable please enter 'Not Applicable'",
        "HTAN ID associated with a patient based on HTAN ID SOP (eg HTANx_yyy )",
        "Yes/No/unknown indicator to identify whether a patient has had a new tumor event after initial treatment.",
        "The text term used to describe the classification of rhabdomyosarcoma tumors, as defined by the Intergroup Rhabdomyosarcoma Study (IRS).",
        "The percentage of tumor cells spread locally in a malignant neoplasm through infiltration or destruction of adjacent tissue.",
        "The text term used to describe whether the patient had non-nodal regional disease.",
        "Number of days between the date used for index and the date the patient's disease was formally confirmed as progression-free. If not applicable please enter 'Not Applicable'",
        "Text that describes the kind of disease present in the tumor specimen as related to a specific timepoint.",
        "The text term used to describe the malignant status of the peritoneal fluid determined by cytologic testing.",
        "The number of mitoses identified under the microscope in tumors. The method of counting varies, according to the specific tumor examined. Usually, the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.",
        "Text term to specify the location of the supratentorial tumor.",
        "Name of HTAN Center e.g. HTAN HTAPP",
        "Synapse ID of manifest containing file annotation",
        "Latest version of metadata manifest"
    ],
    "sample_rows": [
        {
            "ISS_Stage": null,
            "Tumor_Depth": null,
            "Residual_Disease": null,
            "International_Prognostic_Index": null,
            "Days_to_Last_Known_Disease_Status": "6573",
            "Primary_Gleason_Grade": null,
            "IRS_Group": null,
            "AJCC_Clinical_M": null,
            "Lymphatic_Invasion_Present": "No",
            "Lymph_Nodes_Tested": null,
            "Anaplasia_Present": "unknown",
            "Gleason_Grade_Tertiary": null,
            "AJCC_Clinical_N": null,
            "Breslow_Thickness": null,
            "Progression_or_Recurrence_Type": null,
            "Days_to_Progression": null,
            "Margin_Distance": null,
            "Cog_Neuroblastoma_Risk_Group": null,
            "Prior_Treatment": "Not Allowed To Collect",
            "INSS_Stage": null,
            "Days_to_Last_Follow_up": "6573",
            "Greatest_Tumor_Dimension": null,
            "Synchronous_Malignancy": null,
            "Tumor_Largest_Dimension_Diameter": null,
            "Prior_Malignancy": "No",
            "Days_to_Recurrence": "Not Applicable",
            "Tumor_Confined_to_Organ_of_Origin": "Yes",
            "INPC_Histologic_Group": null,
            "Micropapillary_Features": null,
            "Ovarian_Specimen_Status": null,
            "entityId": null,
            "Margins_Involved_Site": null,
            "Metastasis_at_Diagnosis": "No Metastasis",
            "IGCCCG_Stage": null,
            "Primary_Diagnosis": "Glioblastoma",
            "Laterality": null,
            "Morphology": "9440",
            "Cog_Rhabdomyosarcoma_Risk_Group": null,
            "Tumor_Grade": "G4",
            "Gross_Tumor_Weight": null,
            "Perineural_Invasion_Present": "No",
            "Ovarian_Surface_Involvement": null,
            "Method_of_Diagnosis": "Autopsy",
            "Pregnant_at_Diagnosis": null,
            "Mitosis_Karyorrhexis_Index": null,
            "AJCC_Clinical_T": null,
            "Secondary_Gleason_Grade": null,
            "Id": "14eab71a-1107-405a-b785-327ddb3f597d",
            "Lymph_Node_Involved_Site": null,
            "Metastasis_at_Diagnosis_Site": null,
            "Tumor_Focality": "unknown",
            "First_Symptom_Prior_to_Diagnosis": "Not Reported",
            "Last_Known_Disease_Status": "With tumor",
            "Progression_or_Recurrence_Anatomic_Site": null,
            "Vascular_Invasion_Present": "unknown",
            "Component": "Diagnosis",
            "Vascular_Invasion_Type": "unknown",
            "AJCC_Pathologic_N": null,
            "INRG_Stage": null,
            "WHO_NTE_Grade": null,
            "Site_of_Resection_or_Biopsy": "Brain NOS",
            "Anaplasia_Present_Type": null,
            "AJCC_Pathologic_Stage": null,
            "AJCC_Clinical_Stage": null,
            "Year_of_Diagnosis": null,
            "Non_Nodal_Tumor_Deposits": null,
            "Tissue_or_Organ_of_Origin": "Brain NOS",
            "Age_at_Diagnosis": "18250",
            "AJCC_Staging_System_Edition": null,
            "INPC_Grade": null,
            "Best_Overall_Response": null,
            "Medulloblastoma_Molecular_Classification": null,
            "AJCC_Pathologic_M": null,
            "Gleason_Grade_Group": null,
            "Lymph_Nodes_Positive": null,
            "Gleason_Patterns_Percent": null,
            "WHO_CNS_Grade": "Grade IV",
            "AJCC_Pathologic_T": null,
            "Days_to_Diagnosis": null,
            "HTAN_Participant_ID": "HTA12_113",
            "Progression_or_Recurrence": "No",
            "IRS_Stage": null,
            "Percent_Tumor_Invasion": null,
            "Non_Nodal_Regional_Disease": null,
            "Days_to_Progression_Free": null,
            "Classification_of_Tumor": "unknown",
            "Peritoneal_Fluid_Cytological_Status": null,
            "Mitotic_Count": null,
            "Supratentorial_Localization": "Not Reported",
            "HTAN_Center": "HTAN WUSTL",
            "Manifest_Id": "syn52257039",
            "Manifest_Version": 6
        },
        {
            "ISS_Stage": null,
            "Tumor_Depth": null,
            "Residual_Disease": null,
            "International_Prognostic_Index": null,
            "Days_to_Last_Known_Disease_Status": "6573",
            "Primary_Gleason_Grade": null,
            "IRS_Group": null,
            "AJCC_Clinical_M": null,
            "Lymphatic_Invasion_Present": "No",
            "Lymph_Nodes_Tested": null,
            "Anaplasia_Present": "unknown",
            "Gleason_Grade_Tertiary": null,
            "AJCC_Clinical_N": null,
            "Breslow_Thickness": null,
            "Progression_or_Recurrence_Type": "Local",
            "Days_to_Progression": null,
            "Margin_Distance": null,
            "Cog_Neuroblastoma_Risk_Group": null,
            "Prior_Treatment": "Not Allowed To Collect",
            "INSS_Stage": null,
            "Days_to_Last_Follow_up": "6573",
            "Greatest_Tumor_Dimension": null,
            "Synchronous_Malignancy": null,
            "Tumor_Largest_Dimension_Diameter": null,
            "Prior_Malignancy": "No",
            "Days_to_Recurrence": "18249",
            "Tumor_Confined_to_Organ_of_Origin": "Yes",
            "INPC_Histologic_Group": null,
            "Micropapillary_Features": null,
            "Ovarian_Specimen_Status": null,
            "entityId": null,
            "Margins_Involved_Site": null,
            "Metastasis_at_Diagnosis": "No Metastasis",
            "IGCCCG_Stage": null,
            "Primary_Diagnosis": "Astrocytoma anaplastic",
            "Laterality": null,
            "Morphology": "9401",
            "Cog_Rhabdomyosarcoma_Risk_Group": null,
            "Tumor_Grade": "G3",
            "Gross_Tumor_Weight": null,
            "Perineural_Invasion_Present": "No",
            "Ovarian_Surface_Involvement": null,
            "Method_of_Diagnosis": "Autopsy",
            "Pregnant_at_Diagnosis": null,
            "Mitosis_Karyorrhexis_Index": null,
            "AJCC_Clinical_T": null,
            "Secondary_Gleason_Grade": null,
            "Id": "6d349ef0-c8a9-432a-a2e2-e1fa718279c8",
            "Lymph_Node_Involved_Site": null,
            "Metastasis_at_Diagnosis_Site": null,
            "Tumor_Focality": "unknown",
            "First_Symptom_Prior_to_Diagnosis": "Not Reported",
            "Last_Known_Disease_Status": "With tumor",
            "Progression_or_Recurrence_Anatomic_Site": "Brain NOS",
            "Vascular_Invasion_Present": "unknown",
            "Component": "Diagnosis",
            "Vascular_Invasion_Type": "unknown",
            "AJCC_Pathologic_N": null,
            "INRG_Stage": null,
            "WHO_NTE_Grade": null,
            "Site_of_Resection_or_Biopsy": "Brain NOS",
            "Anaplasia_Present_Type": null,
            "AJCC_Pathologic_Stage": null,
            "AJCC_Clinical_Stage": null,
            "Year_of_Diagnosis": null,
            "Non_Nodal_Tumor_Deposits": null,
            "Tissue_or_Organ_of_Origin": "Brain NOS",
            "Age_at_Diagnosis": "17155",
            "AJCC_Staging_System_Edition": null,
            "INPC_Grade": null,
            "Best_Overall_Response": null,
            "Medulloblastoma_Molecular_Classification": null,
            "AJCC_Pathologic_M": null,
            "Gleason_Grade_Group": null,
            "Lymph_Nodes_Positive": null,
            "Gleason_Patterns_Percent": null,
            "WHO_CNS_Grade": "Grade III",
            "AJCC_Pathologic_T": null,
            "Days_to_Diagnosis": null,
            "HTAN_Participant_ID": "HTA12_114",
            "Progression_or_Recurrence": "Yes - Progression or Recurrence",
            "IRS_Stage": null,
            "Percent_Tumor_Invasion": null,
            "Non_Nodal_Regional_Disease": null,
            "Days_to_Progression_Free": null,
            "Classification_of_Tumor": "unknown",
            "Peritoneal_Fluid_Cytological_Status": null,
            "Mitotic_Count": null,
            "Supratentorial_Localization": "Not Reported",
            "HTAN_Center": "HTAN WUSTL",
            "Manifest_Id": "syn52257039",
            "Manifest_Version": 6
        },
        {
            "ISS_Stage": null,
            "Tumor_Depth": null,
            "Residual_Disease": null,
            "International_Prognostic_Index": null,
            "Days_to_Last_Known_Disease_Status": "6934",
            "Primary_Gleason_Grade": null,
            "IRS_Group": null,
            "AJCC_Clinical_M": null,
            "Lymphatic_Invasion_Present": null,
            "Lymph_Nodes_Tested": null,
            "Anaplasia_Present": null,
            "Gleason_Grade_Tertiary": null,
            "AJCC_Clinical_N": null,
            "Breslow_Thickness": null,
            "Progression_or_Recurrence_Type": null,
            "Days_to_Progression": null,
            "Margin_Distance": null,
            "Cog_Neuroblastoma_Risk_Group": null,
            "Prior_Treatment": null,
            "INSS_Stage": null,
            "Days_to_Last_Follow_up": "6934",
            "Greatest_Tumor_Dimension": null,
            "Synchronous_Malignancy": null,
            "Tumor_Largest_Dimension_Diameter": null,
            "Prior_Malignancy": null,
            "Days_to_Recurrence": "0",
            "Tumor_Confined_to_Organ_of_Origin": null,
            "INPC_Histologic_Group": null,
            "Micropapillary_Features": null,
            "Ovarian_Specimen_Status": null,
            "entityId": "syn25126720",
            "Margins_Involved_Site": null,
            "Metastasis_at_Diagnosis": null,
            "IGCCCG_Stage": null,
            "Primary_Diagnosis": "Ductal carcinoma in situ NOS",
            "Laterality": null,
            "Morphology": "Cribriform, Solid",
            "Cog_Rhabdomyosarcoma_Risk_Group": null,
            "Tumor_Grade": "High Grade",
            "Gross_Tumor_Weight": null,
            "Perineural_Invasion_Present": null,
            "Ovarian_Surface_Involvement": null,
            "Method_of_Diagnosis": null,
            "Pregnant_at_Diagnosis": null,
            "Mitosis_Karyorrhexis_Index": null,
            "AJCC_Clinical_T": null,
            "Secondary_Gleason_Grade": null,
            "Id": "2fbc858d-1f59-48a7-994b-0caba22383a8",
            "Lymph_Node_Involved_Site": null,
            "Metastasis_at_Diagnosis_Site": null,
            "Tumor_Focality": null,
            "First_Symptom_Prior_to_Diagnosis": null,
            "Last_Known_Disease_Status": "Tumor free",
            "Progression_or_Recurrence_Anatomic_Site": null,
            "Vascular_Invasion_Present": null,
            "Component": "Diagnosis",
            "Vascular_Invasion_Type": null,
            "AJCC_Pathologic_N": null,
            "INRG_Stage": null,
            "WHO_NTE_Grade": null,
            "Site_of_Resection_or_Biopsy": "Upper-outer quadrant of breast",
            "Anaplasia_Present_Type": null,
            "AJCC_Pathologic_Stage": null,
            "AJCC_Clinical_Stage": null,
            "Year_of_Diagnosis": "2006",
            "Non_Nodal_Tumor_Deposits": null,
            "Tissue_or_Organ_of_Origin": "Breast NOS",
            "Age_at_Diagnosis": "26260.0",
            "AJCC_Staging_System_Edition": null,
            "INPC_Grade": null,
            "Best_Overall_Response": null,
            "Medulloblastoma_Molecular_Classification": null,
            "AJCC_Pathologic_M": null,
            "Gleason_Grade_Group": null,
            "Lymph_Nodes_Positive": null,
            "Gleason_Patterns_Percent": null,
            "WHO_CNS_Grade": null,
            "AJCC_Pathologic_T": null,
            "Days_to_Diagnosis": null,
            "HTAN_Participant_ID": "HTA6_7",
            "Progression_or_Recurrence": "No",
            "IRS_Stage": null,
            "Percent_Tumor_Invasion": null,
            "Non_Nodal_Regional_Disease": null,
            "Days_to_Progression_Free": null,
            "Classification_of_Tumor": null,
            "Peritoneal_Fluid_Cytological_Status": null,
            "Mitotic_Count": null,
            "Supratentorial_Localization": null,
            "HTAN_Center": "HTAN Duke",
            "Manifest_Id": "syn39263335",
            "Manifest_Version": 4
        },
        {
            "ISS_Stage": null,
            "Tumor_Depth": null,
            "Residual_Disease": null,
            "International_Prognostic_Index": null,
            "Days_to_Last_Known_Disease_Status": "9182",
            "Primary_Gleason_Grade": null,
            "IRS_Group": null,
            "AJCC_Clinical_M": null,
            "Lymphatic_Invasion_Present": null,
            "Lymph_Nodes_Tested": null,
            "Anaplasia_Present": null,
            "Gleason_Grade_Tertiary": null,
            "AJCC_Clinical_N": null,
            "Breslow_Thickness": null,
            "Progression_or_Recurrence_Type": null,
            "Days_to_Progression": null,
            "Margin_Distance": null,
            "Cog_Neuroblastoma_Risk_Group": null,
            "Prior_Treatment": null,
            "INSS_Stage": null,
            "Days_to_Last_Follow_up": "9182",
            "Greatest_Tumor_Dimension": null,
            "Synchronous_Malignancy": null,
            "Tumor_Largest_Dimension_Diameter": null,
            "Prior_Malignancy": null,
            "Days_to_Recurrence": "Not Applicable",
            "Tumor_Confined_to_Organ_of_Origin": null,
            "INPC_Histologic_Group": null,
            "Micropapillary_Features": null,
            "Ovarian_Specimen_Status": null,
            "entityId": "syn25129104",
            "Margins_Involved_Site": null,
            "Metastasis_at_Diagnosis": null,
            "IGCCCG_Stage": null,
            "Primary_Diagnosis": "Ductal carcinoma in situ NOS",
            "Laterality": null,
            "Morphology": "unknown",
            "Cog_Rhabdomyosarcoma_Risk_Group": null,
            "Tumor_Grade": "High Grade",
            "Gross_Tumor_Weight": null,
            "Perineural_Invasion_Present": null,
            "Ovarian_Surface_Involvement": null,
            "Method_of_Diagnosis": null,
            "Pregnant_at_Diagnosis": null,
            "Mitosis_Karyorrhexis_Index": null,
            "AJCC_Clinical_T": null,
            "Secondary_Gleason_Grade": null,
            "Id": "c620575c-c4dd-4bb5-aee3-c0aad9d7a8ad",
            "Lymph_Node_Involved_Site": null,
            "Metastasis_at_Diagnosis_Site": null,
            "Tumor_Focality": null,
            "First_Symptom_Prior_to_Diagnosis": null,
            "Last_Known_Disease_Status": "Tumor free",
            "Progression_or_Recurrence_Anatomic_Site": null,
            "Vascular_Invasion_Present": null,
            "Component": "Diagnosis",
            "Vascular_Invasion_Type": null,
            "AJCC_Pathologic_N": null,
            "INRG_Stage": null,
            "WHO_NTE_Grade": null,
            "Site_of_Resection_or_Biopsy": "Breast NOS",
            "Anaplasia_Present_Type": null,
            "AJCC_Pathologic_Stage": null,
            "AJCC_Clinical_Stage": null,
            "Year_of_Diagnosis": "1989",
            "Non_Nodal_Tumor_Deposits": null,
            "Tissue_or_Organ_of_Origin": "Breast NOS",
            "Age_at_Diagnosis": "19458.0",
            "AJCC_Staging_System_Edition": null,
            "INPC_Grade": null,
            "Best_Overall_Response": null,
            "Medulloblastoma_Molecular_Classification": null,
            "AJCC_Pathologic_M": null,
            "Gleason_Grade_Group": null,
            "Lymph_Nodes_Positive": null,
            "Gleason_Patterns_Percent": null,
            "WHO_CNS_Grade": null,
            "AJCC_Pathologic_T": null,
            "Days_to_Diagnosis": null,
            "HTAN_Participant_ID": "HTA6_1042",
            "Progression_or_Recurrence": "No",
            "IRS_Stage": null,
            "Percent_Tumor_Invasion": null,
            "Non_Nodal_Regional_Disease": null,
            "Days_to_Progression_Free": null,
            "Classification_of_Tumor": null,
            "Peritoneal_Fluid_Cytological_Status": null,
            "Mitotic_Count": null,
            "Supratentorial_Localization": null,
            "HTAN_Center": "HTAN Duke",
            "Manifest_Id": "syn39263335",
            "Manifest_Version": 4
        },
        {
            "ISS_Stage": null,
            "Tumor_Depth": null,
            "Residual_Disease": null,
            "International_Prognostic_Index": null,
            "Days_to_Last_Known_Disease_Status": "9183",
            "Primary_Gleason_Grade": null,
            "IRS_Group": null,
            "AJCC_Clinical_M": null,
            "Lymphatic_Invasion_Present": null,
            "Lymph_Nodes_Tested": null,
            "Anaplasia_Present": null,
            "Gleason_Grade_Tertiary": null,
            "AJCC_Clinical_N": null,
            "Breslow_Thickness": null,
            "Progression_or_Recurrence_Type": null,
            "Days_to_Progression": null,
            "Margin_Distance": null,
            "Cog_Neuroblastoma_Risk_Group": null,
            "Prior_Treatment": null,
            "INSS_Stage": null,
            "Days_to_Last_Follow_up": "9183",
            "Greatest_Tumor_Dimension": null,
            "Synchronous_Malignancy": null,
            "Tumor_Largest_Dimension_Diameter": null,
            "Prior_Malignancy": null,
            "Days_to_Recurrence": "Not Applicable",
            "Tumor_Confined_to_Organ_of_Origin": null,
            "INPC_Histologic_Group": null,
            "Micropapillary_Features": null,
            "Ovarian_Specimen_Status": null,
            "entityId": "syn25129107",
            "Margins_Involved_Site": null,
            "Metastasis_at_Diagnosis": null,
            "IGCCCG_Stage": null,
            "Primary_Diagnosis": "Ductal carcinoma in situ NOS",
            "Laterality": null,
            "Morphology": "unknown",
            "Cog_Rhabdomyosarcoma_Risk_Group": null,
            "Tumor_Grade": "Low Grade",
            "Gross_Tumor_Weight": null,
            "Perineural_Invasion_Present": null,
            "Ovarian_Surface_Involvement": null,
            "Method_of_Diagnosis": null,
            "Pregnant_at_Diagnosis": null,
            "Mitosis_Karyorrhexis_Index": null,
            "AJCC_Clinical_T": null,
            "Secondary_Gleason_Grade": null,
            "Id": "df0f40ce-0eb5-458f-8396-426c8d58f1ef",
            "Lymph_Node_Involved_Site": null,
            "Metastasis_at_Diagnosis_Site": null,
            "Tumor_Focality": null,
            "First_Symptom_Prior_to_Diagnosis": null,
            "Last_Known_Disease_Status": "Tumor free",
            "Progression_or_Recurrence_Anatomic_Site": null,
            "Vascular_Invasion_Present": null,
            "Component": "Diagnosis",
            "Vascular_Invasion_Type": null,
            "AJCC_Pathologic_N": null,
            "INRG_Stage": null,
            "WHO_NTE_Grade": null,
            "Site_of_Resection_or_Biopsy": "Breast NOS",
            "Anaplasia_Present_Type": null,
            "AJCC_Pathologic_Stage": null,
            "AJCC_Clinical_Stage": null,
            "Year_of_Diagnosis": "1988",
            "Non_Nodal_Tumor_Deposits": null,
            "Tissue_or_Organ_of_Origin": "Breast NOS",
            "Age_at_Diagnosis": "25966.0",
            "AJCC_Staging_System_Edition": null,
            "INPC_Grade": null,
            "Best_Overall_Response": null,
            "Medulloblastoma_Molecular_Classification": null,
            "AJCC_Pathologic_M": null,
            "Gleason_Grade_Group": null,
            "Lymph_Nodes_Positive": null,
            "Gleason_Patterns_Percent": null,
            "WHO_CNS_Grade": null,
            "AJCC_Pathologic_T": null,
            "Days_to_Diagnosis": null,
            "HTAN_Participant_ID": "HTA6_1076",
            "Progression_or_Recurrence": "No",
            "IRS_Stage": null,
            "Percent_Tumor_Invasion": null,
            "Non_Nodal_Regional_Disease": null,
            "Days_to_Progression_Free": null,
            "Classification_of_Tumor": null,
            "Peritoneal_Fluid_Cytological_Status": null,
            "Mitotic_Count": null,
            "Supratentorial_Localization": null,
            "HTAN_Center": "HTAN Duke",
            "Manifest_Id": "syn39263335",
            "Manifest_Version": 4
        }
    ]
}